|
1
|
Numasaki H, Nakada Y, Ohba H and Nakamura
K: Japanese Structure Survey of Radiation Oncology in 2019 (First
Report): Japanese Society for Radiation Oncology; JASTRO Database
Committee, 2022. https://www.jastro.or.jp/medicalpersonnel/data_center/JASTRO_NSS_2019-01.pdf,
Accessed July 7, 2024 (In Japanese).
|
|
2
|
Ministry of Health, Labour and Welfare:
Summary of Static/Dynamic Surveys of Medical Institutions and
Hospital Report in 2020. https://www.mhlw.go.jp/english/database/db-hss/mih_report_2020.html.
Accessed February 28, 2024 (In Japanese).
|
|
3
|
Iwamoto RR and Maher KE: Radiation therapy
for prostate cancer. Semin Oncol Nurs. 17:90–100. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Japanese Society for Radiation Oncology:
JASTRO Guidelines 2020 for Radiotherapy Treatment Planning. 5th
edition. Kanehara & Co. Ltd., 2020 (In Japanese).
|
|
5
|
David RV, Kahokehr AA, Lee J, Watson DI,
Leung J and O'Callaghan ME: Incidence of genitourinary
complications following radiation therapy for localized prostate
cancer. World J Urol. 40:2411–2422. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Monzen S, Tatsuya Ueno, Mitsuru Chiba and
Yasushi Mariya: Exploratory study of biomarkers for radiation
exposure adverse events. Nihon Hoshasen Gijutsu Gakkai Zasshi.
75:480–85. 2019.(In Japanese).
|
|
7
|
Franken NA, Oei AL, Kok HP, Rodermond HM,
Sminia P, Crezee J, Stalpers LJ and Barendsen GW: Cell survival and
radiosensitisation: Modulation of the linear and quadratic
parameters of the LQ model (Review). Int J Oncol. 42:1501–1515.
2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Annede P, Cosset JM, Van Limbergen E,
Deutsch E, Haie-Meder C and Chargari C: Radiobiology: Foundation
and new insights in modeling brachytherapy effects. Semin Radiat
Oncol. 30:4–15. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Meng W, Pan H, Sha Y, Zhai X, Xing A,
Lingampelly SS, Sripathi SR, Wang Y and Li K: Metabolic connectome
and its role in the prediction, diagnosis, and treatment of complex
diseases. Metabolites. 14(93)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mottet N, Bellmunt J, Bolla M, Briers E,
Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau
S, et al: EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1:
Screening, diagnosis, and local treatment with curative intent. Eur
Urol. 71:618–629. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tøndel H, Lund JÅ, Lydersen S, Wanderås
AD, Aksnessæther B, Jensen CA, Kaasa S and Solberg A: Radiotherapy
for prostate cancer-does daily image guidance with tighter margins
improve patient reported outcomes compared to weekly orthogonal
verified irradiation? Results from a randomized controlled trial.
Radiother Oncol. 126:229–235. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hunte SO, Clark CH, Zyuzikov N and Nisbet
A: Volumetric modulated arc therapy (VMAT): A review of clinical
outcomes-what is the clinical evidence for the most effective
implementation? Br J Radiol. 95(20201289)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Halperin EC, Wazer DE, Perez CA and Brady
LW: Perez and Brady's principles and practice of radiation
oncology. 7th edition. Wolters Kluwer, PA, 2018.
|
|
14
|
Ghanem AI, Elsaid AA, Elshaikh MA and
Khedr GA: Volumetric-modulated arc radiotherapy with daily
image-guidance carries better toxicity profile for higher risk
prostate cancer. Asian Pac J Cancer Prev. 22:61–68. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Eastham JA, Auffenberg GB, Barocas DA,
Chou R, Crispino T, Davis JW, Eggener S, Horwitz EM, Kane CJ,
Kirkby E, et al: Clinically localized prostate cancer: AUA/ASTRO
guideline. Part Ⅲ: Principles of radiation and future directions. J
Urol. 208:26–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hubenak JR, Zhang Q, Branch CD and
Kronowitz SJ: Mechanisms of injury to normal tissue after
radiotherapy: A review. Plast Reconstr Surg. 133:49e–56e.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pang Z, Chong J, Zhou G, de Lima Morais
DA, Chang L, Barrette M, Gauthier C, Jacques PÉ, Li S and Xia J:
MetaboAnalyst 5.0: Narrowing the gap between raw spectra and
functional insights. Nucleic Acids Res. 49(W1):W388–W396.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Erben V, Poschet G, Schrotz-King P and
Brenner H: Comparing metabolomics profiles in various types of
liquid biopsies among screening participants with and without
advanced colorectal neoplasms. Diagnostics (Basel).
11(561)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhai G, Pelletier JP, Liu M, Aitken D,
Randell E, Rahman P, Jones G and Martel-Pelletier J: Activation of
the phosphatidylcholine to lysophosphatidylcholine pathway is
associated with osteoarthritis knee cartilage volume loss over
time. Sci Rep. 9(9648)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vadas P, Browning J, Edelson J and
Pruzanski W: Extracellular phospholipase A2 expression and
inflammation: The relationship with associated disease states. J
Lipid Mediat. 8:1–30. 1993.PubMed/NCBI
|
|
21
|
Wegener D, Berger B, Outtagarts Z, Zips D,
Paulsen F, Bleif M, Thorwarth D, Alber M, Dohm O and Müller AC:
Prospective evaluation of probabilistic dose-escalated IMRT in
prostate cancer. Radiol Oncol. 55:88–96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Spratt DE, Pei X, Yamada J, Kollmeier MA,
Cox B and Zelefsky MJ: Long-term survival and toxicity in patients
treated with high-dose intensity modulated radiation therapy for
localized prostate cancer. Int J Radiat Oncol Biol Phys.
85:686–692. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Greiner M, Pfeiffer D and Smith RD:
Principles and practical application of the receiver-operating
characteristic analysis for diagnostic tests. Prev Vet Med.
45:23–41. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Alicikus ZA, Yamada Y, Zhang Z, Pei X,
Hunt M, Kollmeier M, Cox B and Zelefsky MJ: Ten-year outcomes of
high-dose, intensity-modulated radiotherapy for localized prostate
cancer. Cancer. 117:1429–1437. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zelefsky MJ, Levin EJ, Hunt M, Yamada Y,
Shippy AM, Jackson A and Amols HI: Incidence of late rectal and
urinary toxicities after 3-dimensional conformal radiotherapy and
intensity-modulated radiotherapy for localized prostate cancer. Int
J Radiat Oncol Biol Phys. 70:1124–1129. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Peeters ST, Heemsbergen WD, Van Putten WL,
Slot A, Tabak H, Mens JW, Lebesque JV and Koper PC: Acute and late
complications after radiotherapy for prostate cancer: Results of a
multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat
Oncol Biol Phys. 61:1019–1034. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Oscarsson N, Müller B, Rosén A, Lodding P,
Mölne J, Giglio D, Hjelle KM, Vaagbø G, Hyldegaard O, Vangedal M,
et al: Radiation-induced cystitis treated with hyperbaric oxygen
therapy (RICH-ART): A randomised, controlled, phase 2-3 trial.
Lancet Oncol. 20:1602–1614. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dykstra MA, Switzer N, Eisner R, Tso V,
Foshaug R, Ismond K, Fedorak R and Wang H: Urine metabolomics as a
predictor of patient tolerance and response to adjuvant
chemotherapy in colorectal cancer. Mol Clin Oncol. 7:767–770.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li X, Nakayama K, Goto T, kimura H,
Akamatsu S, Hayashi Y, Fujita K, Kobayashi T, Shimizu K, Nonomura
N, et al: High level of
phosphatidylcholines/lysophosphatidylcholine ratio in urine is
associated with prostate cancer. Cancer Sci. 112:4292–4302.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kartikasari AER, Huertas CS, Mitchell A
and Plebanski M: Tumor-Induced inflammatory cytokines and the
emerging diagnostic devices for cancer detection and prognosis.
Front Oncol. 11(692142)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao H, Xi C, Tian M, Lu X, Cai TJ, Li S,
Tian XL, Gao L, Liu HX, Liu KH and Liu QJ: Identification of
potential radiation responsive metabolic biomarkers in plasma of
rats exposed to different doses of cobalt-60 gamma rays. Dose
Response. 18(1559325820979570)2020.PubMed/NCBI View Article : Google Scholar
|
